CMV IgM EIA, in vitro diagnostic.
FDA Device Recall #Z-0342-2023 — Class II — October 19, 2022
Recall Summary
| Recall Number | Z-0342-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 19, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bio-Rad Laboratories, Inc. |
| Location | Redmond, WA |
| Product Type | Devices |
| Quantity | 180 kits |
Product Description
CMV IgM EIA, in vitro diagnostic.
Reason for Recall
Due to an unusual increase in the positivity rate with human IgM antibodies to cytomegalovirus (CMV) Enzyme Immunoassay (EIA).
Distribution Pattern
U.S.: CA, CO, FL, GA, HI, IA, MA, MN, NC, NH, NJ, PA, TN, and TX O.U.S.: None
Lot / Code Information
Catalog Number: 25178 UDI-DI Code: 00847865010733 Lot Numbers: B02022 E10022 G05022
Other Recalls from Bio-Rad Laboratories, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2515-2025 | Class II | Platelia Toxo IgM Catalog Number 26211 UDI Cod... | May 30, 2025 |
| Z-1572-2023 | Class II | BioPlex 2200 REF 665-2050, APLS IgM Pack, APLS ... | Feb 28, 2023 |
| Z-1377-2023 | Class II | BioPlex 2200, Anti-CCP Reagent Pack, REF 665-32... | Feb 21, 2023 |
| Z-1378-2023 | Class II | BioPlex 2200, Anti-CCP Calibrator Set, REF 663-... | Feb 21, 2023 |
| Z-1096-2022 | Class II | BioPlex 2200 REF 12000670 ToRC IgM Reagent Pack | Apr 14, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.